| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/17/2010 | US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases |
| 08/17/2010 | US7776894 sensitization cancer cells to apoptosis using acetyl isogambogic acid, celastrolor celastrol derivatives such as (2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-N,N,2,4a,6a,6a,9,14a-octamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxamide; antimetastasis agents |
| 08/17/2010 | US7776893 administering N-(3,5-Dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide in a dosage form selected from an oral dosage form, an injectable dosage form, and an infusible dosage form |
| 08/17/2010 | US7776892 Fungicidal composition comprising a pyridylethylbenzamide derivative and a compound capable of inhibiting the spores germination or mycelium growth by acting on different metabolic routes |
| 08/17/2010 | US7776891 antagonists of very late antigen-4 integrin; ulcerative colitis, Crohn's disease, asthma, multiple sclerosis, rheumatoid arthritis; N-{N-[(3-Cyanobenzene)sulfonyl]-4(R)-[3,3-difluoropiperidinyl]-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl)amino]-(L)-phenylalanine ethyl ester |
| 08/17/2010 | US7776890 1H-indazole compounds |
| 08/17/2010 | US7776889 also known as protease activated receptor-1 (PAR-1) antagonists or as cannabinoid (CB2) receptor antagonists, used for treating thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, congestive heart failure and cancer |
| 08/17/2010 | US7776888 such as 3-[2-(2-methoxy-ethoxymethyl)-6-trifluoromethyl-pyridine-3-carbonyl]-1,5-dimethyl-8-oxa-bicyclo[3.2.1]oct-6-ene-2,4-dione, used for controlling undesired plant growth or weeds |
| 08/17/2010 | US7776886 For neurological and psychiatric disorders associated with glycinergic or glutamatergic neur-transmission dysfunction; schizophrenia; 2-amino-6-chloro-N-{[4-(cyclopropylmethyl)-1-(propylsulfonyl)piperidin-4-yl]methyl}benzamide |
| 08/17/2010 | US7776885 Benzimidazolone compounds having 5-HT4 receptor agonistic activity |
| 08/17/2010 | US7776884 Cyclic derivatives as modulators of chemokine receptors activity |
| 08/17/2010 | US7776883 Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC) |
| 08/17/2010 | US7776882 such as 3-(2-Amino-6-phenoxy-3,4-dihydro-quinolin-3-yl)-N-cyclohexyl-N-methyl-propionamide, used in the treatment of Alzheimer's disease and related disorders |
| 08/17/2010 | US7776881 Hyperlipemia therapeutic agent |
| 08/17/2010 | US7776880 glycine transport inhibitors such as trans-threo-2-chloro-N-[(octahydroindolizin-5-yl)phenylmethyl]-3-trifluoromethylbenzamide hydrochloride, used for the treatment of behavioral disorders associated with dementia, psychoses, in particular schizophrenia and side effect reduction induced by neuroleptics |
| 08/17/2010 | US7776879 anticholinergic agents such as Butylthiophen-2-ylmethylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester, having a high affinity for muscarinic M3 receptors, useful for treating respiratory system, urogenital, gastrointestinal and cardiovascular disorders |
| 08/17/2010 | US7776878 Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents |
| 08/17/2010 | US7776877 N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides |
| 08/17/2010 | US7776876 administering cyclic Glycyl-2-Allyl Proline as as neuroprotectants, for the prophylaxis of nervous system disorders |
| 08/17/2010 | US7776875 such as 2'S,3S,4'R)-6-chloro-4'-{5-chloro-2-[1-methyl-1-(1-methyl-piperidin-4-ylcarbamoyl)-ethoxy]-phenyl}-2'-(5-fluoro-2-methyl-phenyl)spiro[3H-indole-3,3'-piperidine]-2,6'(1H)-dione, used as antiproliferative agents, especially, as anticarcinogenic agents |
| 08/17/2010 | US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes |
| 08/17/2010 | US7776873 administering to human in need thereof a pharmaceutical composition comprising an effective amount for providing cytoprotection to the gastric mucosa of a pharmaceutically acceptable salt of revaprazan and a pharmaceutically acceptable carrier |
| 08/17/2010 | US7776872 Diaminopyrimidines as P2X3 and P2X2/3 modulators |
| 08/17/2010 | US7776871 for treatment of focal distonia, tremors, and parkinson's disease |
| 08/17/2010 | US7776870 Methods for modulating Lyn kinase activity and treating related disorders |
| 08/17/2010 | US7776869 protein kinase modulators such as 3-((2-amino-5-pyrimidinyl)ethynyl)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide, useful for the prophylaxis and treatment of inflammation, cancer, rheumatoid arthritis and for reducing blood flow in tumors |
| 08/17/2010 | US7776868 e.g. 6-[(1E)-2-(3,4-dimethoxyphenyl)vinyl]-3-ethyl-1,5-dimethyl-1,3-dihydrothiopheno[2,3-d]pyrimidine-2,4-dione; neurodegenerative disorders, antiischemic agent, antidepressant, attention deficit disorder, hepatic fibrosis, cirrhosis of the liver, and drug addiction |
| 08/17/2010 | US7776867 Furanopyrimidines |
| 08/17/2010 | US7776866 Deuterium-enriched risperidone |
| 08/17/2010 | US7776865 checkpoint kinase inhibitors; for treating and preventing proliferative diseases such as cancer, inflammation and arthritis, neurodegenerative diseases such Alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases |
| 08/17/2010 | US7776864 Fused bicyclic pyrimidines |
| 08/17/2010 | US7776863 administering therapeutically effective amount of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine or salt thereof, with at least one other agent used for treatment of AIDS or HIV such as didanosine, delavirdine, ritonavir, enfuvirtide |
| 08/17/2010 | US7776862 Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| 08/17/2010 | US7776861 Cycloheteroalkenyl compounds used as analgesics and for treating incontinence, inflammatory bowel disease, Parkinson's disease, amyotrophic lateral sclerosis, dementia, epilepsy, retinopathy, pruritus, psychoses, Huntington's disease, headaches, vomiting, dyskinesia or as anxiolytics and antidepressants |
| 08/17/2010 | US7776860 Partial neutralization of the tri-hydrochloric acid salt directly results in the monohydrochloric acid salt and hydrates; serotonin receptor modulators having 5-HT1A-agonistic as well as 5-HT1D-antagonistic activity |
| 08/17/2010 | US7776859 (S)-2-(3-chloro-4-cyano-2-methylphenyl)-N-(4-(4-(ethylsulfonyl)piperazin-1-yl)butyl)-3-oxo-hexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxamide, used as anticarcinogenic agents |
| 08/17/2010 | US7776858 rheumatoid arthritis |
| 08/17/2010 | US7776856 Fused pyrimidines such as 2-(1H-Indol -4-yl )-6-(4-methyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine, uses as phosphatidylinositol 3-kinase inhibitors, for the treatment of cancer, viral infection, inflammation, metabolic, endocrine, immune and cardiovascular disorders |
| 08/17/2010 | US7776855 Antimicrobial oxazolidinone prodrugs |
| 08/17/2010 | US7776854 1,3-benzothiazol-2-yl(2-{[4-(morpholin-4-ylmethyl)benzyl]oxy}pyrimidin-4-yl)-acetonitrile; (or benzimidazole or benzoxazole 2-acetonitrile derivatives); systemic sclerosis, CREST, sine scleroderma, cirrhosis, heart failure; inhibitors of JNK (c-Jun N-terminal Kinases) |
| 08/17/2010 | US7776853 Dietetics therapy; lipase inhibitor |
| 08/17/2010 | US7776852 Process for producing highly pure midazolam and salts thereof |
| 08/17/2010 | US7776851 Use of neurokinin antagonists in the treatment of urinary incontinence |
| 08/17/2010 | US7776850 respiratory tract mucositis; administering an antifungal agent and an antibacterial agent, wherein the treatment does not involve the cessation of use of emollients |
| 08/17/2010 | US7776849 used as heat shock protein 90 inhibitors, for the preventing and/or treating for cancer and chronic myelocytic leukemia; antitumor agent; angiogenesis inhibitors; anticarcinorgenic agents |
| 08/17/2010 | US7776847 viricides such as N-(2-(Benzo[d]isothiazol-3- ylamino)ethyl)-4- methylnicotinamide, that inhibit replication and/or proliferation of hepatitis C virus (HCV) |
| 08/17/2010 | US7776846 Administering a synergistic mixture of a cortisone, hydrocortisone and/or prednisolone derivative; antiasthmatic agents; side effect reduction |
| 08/17/2010 | US7776845 Pharmaceutical compositions |
| 08/17/2010 | US7776844 adminstering N-(phosphonomethyl)-proline free of N-(phosphonomethyl)-glycine or N,N-bis(phosphonomethyl)-glycine to a patient to treat cosmetic conditions and medical disorders, symptoms or syndromes associated with at least one of a nervous, vascular, musculoskeletal or cutaneous system |
| 08/17/2010 | US7776843 water soluble, microparticulates; bone injuries |
| 08/17/2010 | US7776842 nutritional supplements; rheumatic disorders; metabolic disorders |
| 08/17/2010 | US7776840 Methods of use of biomaterial and injectable implant containing biomaterial |
| 08/17/2010 | US7776839 Pharmaceutical compositions including alginates and methods of preparing and using same |
| 08/17/2010 | US7776838 such as AZT; derivatives of uridine or cytidine such as triacetyluridine and ethoxycarbonyluridine or triacetylcytidine, capable of attenuating damage to hematopoietic system in animals; interleukins; colony stimulating factors |
| 08/17/2010 | US7776837 RNA aptamers and methods for identifying the same |
| 08/17/2010 | US7776836 RNA aptamers and methods for identifying the same |
| 08/17/2010 | US7776835 Genetically engineered RNA self replicating enzyme for use in removal of repetitve triplet codon associated with muscular dystrophy; gene therapeutics and RNA targeting |
| 08/17/2010 | US7776834 Dinucleotides modified by 2'-deoxy-7-deazaguanosine, arabinoguanosine and a glycerol linker;flexibility in the nature of immune response produced; overcoming of species specificities; vaccines; anticarcinogenic agents; autoimmune disorders; asthma;antiallergens ;bactericides; viricides; parasiticides |
| 08/17/2010 | US7776833 as neuroprotectants for improving of cognitive function and for normalization of psychophysiological status, as well treatment of a of psychological and cardiovascular disorders, diseases caused by substance abuse and a hyperactive immune system in mammals |
| 08/17/2010 | US7776832 Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines |
| 08/17/2010 | US7776831 such as nystatin and flavor modifier; chewable dosages |
| 08/17/2010 | US7776829 lupus; for patients who are refractory or intractable to corticosteroid treatment, and treatment with cyclophosphamide, azathioprine, mycophenolate mofetil, anti-thymocyte-globin, methotrexate and immunoglobulin |
| 08/17/2010 | US7776814 with cyclodextrins, polyoxyethylene glycol; anticancer agents |
| 08/17/2010 | US7776620 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 08/17/2010 | US7776600 For bone/tooth engineering and repair; bone morphogenic proteins; stents; kits |
| 08/17/2010 | US7776595 Ex vivo gene therapy of HIV infection; CD34+ hematopoietic cells being transduced with a viral construct which expresses an anti-HIV agent |
| 08/17/2010 | US7776552 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/17/2010 | US7776545 Detection of toxic gluten oligopeptides refractory to digestion by using antibodies and T cells responsive thereto; producing the antibodies by immunization of an animal |
| 08/17/2010 | US7776541 Psoriasin expression by breast epithelial cells |
| 08/17/2010 | US7776529 For fluorescent detection/quantitation of DNA; kits; staining solutions |
| 08/17/2010 | US7776369 lignan extract comprising a lignan complex including secoisolariciresinol diglucoside;wherein the lignan extract is substantially free of cyanogenic glycosides as determined by measuring free cyanides; use in treating cancer, diabetes, hypertension, lupus, and atherosclerosis |
| 08/17/2010 | US7776366 improve fertility in mammals, including humans and stallions, including an oil cake component, glucosamine derivative, an acid, minerals, vitamins, and a food component, gametogenesis |
| 08/17/2010 | US7776364 N-acetyl-L-carnosine, carnosine, glutathione and cysteine in amounts which, when taken together, are effective to chemically reduce the amount of free radicals which would normally be found in vivo in the eye |
| 08/17/2010 | US7776355 Skin drug delivery system with pads and liquids with insoluble drugs |
| 08/17/2010 | US7776354 Remedies for glomerular diseases |
| 08/17/2010 | US7776353 producing food product containing conjugated linoleic acid esters by combining foodstuff with a conjugated linoleic acid ester composition containing less than 1% total 8,10 octadecadienoic acids, 11,13 octadecadienoic acids, and trans-trans octadecadienoic acids, adding adsorbing agent, antioxidant |
| 08/17/2010 | US7776351 polysiloxane prepolymers with pendant pharmaceutically active leaving groups that are released when hydrolyzed or cured in situ |
| 08/17/2010 | US7776348 Water-in-oil emulsion foundation |
| 08/17/2010 | US7776345 Gastric retention controlled drug delivery system |
| 08/17/2010 | US7776344 for extending clinical utility of interferon (IFN) alpha in treatment of a variety of viral and proliferative disorders; increase efficacy of IFN- alpha and reduce IFN- alpha treatment-related side effects |
| 08/17/2010 | US7776332 infant formula which includes casein protein and whey protein; malnutrition; free of arginine and histidine; has an amino acid profile which is close to that of human milk |
| 08/17/2010 | US7776320 Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex |
| 08/17/2010 | US7776319 Methods and compositions for treatment of ion imbalances |
| 08/17/2010 | US7776315 Pharmaceutical compositions based on anticholinergics and additional active ingredients |
| 08/17/2010 | US7776314 Abuse-proofed dosage system |
| 08/17/2010 | CA2605854C Novel pyridine derivative and pyrimidine derivative (3) |
| 08/17/2010 | CA2585003C An oral preparation having improved bioavailability |
| 08/17/2010 | CA2584968C Drug and food or drink for improving pancreatic functions |
| 08/17/2010 | CA2569691C Methods and compositions for treating ophthalmic conditions with retinyl derivatives |
| 08/17/2010 | CA2562104C Crystalline pyrazole derivative |
| 08/17/2010 | CA2557538C Benzimidazole derivative and use as an angiotensin ii receptor antagonist |
| 08/17/2010 | CA2552766C N-hydroxy-4- {5- [4- (5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine bis(methanesulfonate) |
| 08/17/2010 | CA2551867C Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives |
| 08/17/2010 | CA2547591C Novel compounds and compositions as cathepsin inhibitors |
| 08/17/2010 | CA2545092C Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity |
| 08/17/2010 | CA2530216C The use of an edible acid or the potassium or sodium salt thereof in the treatment of allergy |
| 08/17/2010 | CA2529393C Sustained release formulation for venlafaxine hydrochloride |
| 08/17/2010 | CA2527203C Casr antagonist |
| 08/17/2010 | CA2520207C Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease |
| 08/17/2010 | CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases |